Search company, investor...

Founded Year



Loan | Alive

Total Raised


Last Raised

$250K | 4 yrs ago

About NeuroSky

NeuroSky is a company that specializes in health and wellness biometrics, operating in the wearable technology and mobile solutions sectors. The company offers EEG and ECG biosensors that provide insightful and easy-to-understand biometric data analysis, primarily used for monitoring and analyzing body and mind health. These technologies are primarily utilized in the consumer-facing wearable technology industry. It was founded in 2004 and is based in San Jose, California.

Headquarters Location

125 South Market Street

San Jose, California, 95113,

United States




Expert Collections containing NeuroSky

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

NeuroSky is included in 1 Expert Collection, including Smart Home & Consumer Electronics.


Smart Home & Consumer Electronics

1,234 items

This Collection includes companies developing smart home devices, wearables, home electronics, and other consumer electronics.

NeuroSky Patents

NeuroSky has filed 21 patents.

patents chart

Application Date

Grant Date


Related Topics




Sensors, Biosensors, Biotechnology, Gas sensors, Transducers


Application Date


Grant Date



Related Topics

Sensors, Biosensors, Biotechnology, Gas sensors, Transducers



Latest NeuroSky News

Brain Computer Interface Market is Projected to Gain $5,463.00 Million by 2030: Report by Allied Market Research

Nov 16, 2023

The leading companies of the market include Nihon Kohden Corporation, Advanced Brain Monitoring, Inc., Emotiv, Inc., Cadwell Laboratories Inc., Cortech Solutions, Inc., Guger Technologies, Integra LifeSciences, NeuroSky, Inc., Natus Medical Incorporated., and OpenBCI. These companies have employed different strategies such as mergers, collaborations, acquisitions, etc. to gain an advantage over their peers in the industry. Enquiry Before Buying: Key Industry Developments - On November 2023: Neurolutions, Inc., the leader in the use of non-invasive brain computer interface (BCI) technology for post-stroke therapy partnered with Kandu™ Health, a tech enabled health care services company that is changing the course of stroke recovery and post-acute care. Through this partnership the companies intends to accelerate access to breakthrough brain computer interface (BCI) and remote support for stroke rehabilitation. On October 2023: Butterfly Network, maker of a handheld, smartphone-connected ultrasound system partnered with Forest Neurotech, a tech-enabled research company building a device for stimulating and imaging the brain with ultrasound. Through this partnership the companies intends to develop a whole-brain neural interface utilizing Butterfly's Ultrasound-on-Chip technology. On October 2023: WiMi Hologram Cloud Inc., a leading global Hologram Augmented Reality ("AR") Technology provider launched a hybrid bios-signal-based brain-computer interface (HBS-BCI) that is rapidly gaining prominence. HBS-BCI technology is designed to improve classification accuracy, increase the number of commands, and shorten the time it takes for brain commands to be detected by integrating multiple biological signals. On January 2023: MicroCloud Hologram a Hologram Digital Twins Technology provider, launched its holographic BCI (Brain-Computer Interface) data acquisition system. Holographic technology can be used as an information feedback tool for BCI systems, providing more realistic, prosperous, and stimulating contextual feedback for a more immersive user experience. BCI can be used as an input device for the holographic system, providing more direct and faster input. On May 2022: Blackrock Neurotech acquired spatial computing software firm MindX to bolster its development of technologically advanced brain-computer interface products. BCI use in clinical applications is supported by user-friendly software that decodes neural activity and translates brain signals into digital commands. About Us: Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports Insights" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. We are in professional corporate relations with various companies, and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry. Tags

NeuroSky Frequently Asked Questions (FAQ)

  • When was NeuroSky founded?

    NeuroSky was founded in 2004.

  • Where is NeuroSky's headquarters?

    NeuroSky's headquarters is located at 125 South Market Street, San Jose.

  • What is NeuroSky's latest funding round?

    NeuroSky's latest funding round is Loan.

  • How much did NeuroSky raise?

    NeuroSky raised a total of $12.05M.

  • Who are the investors of NeuroSky?

    Investors of NeuroSky include Paycheck Protection Program, SoftBank, Marubeni, Taiwan Global BioFund, WR Hambrecht + Co. and 4 more.

  • Who are NeuroSky's competitors?

    Competitors of NeuroSky include eSight, Muse, NextMind, Bioness, Freer Logic and 7 more.


Compare NeuroSky to Competitors


Truthtek is a spin-out company from Manchester Metropolitan University with a suite of software for the analysis of non-verbal behaviour in video streams of structured interviews. The technology combines latest psychological research in non-verbal communication with leading image recognition and analysis software. Potential applications include lie detection, where the technology is non-invasive and has shown 85% accuracy in initial trials. MTF has provided initial seed capital to the company to enable it to develop its commercial and market-entry strategy.


DERMING SRL is a private research institute focused on dermatological testing within the cosmetics and pharmaceutical sectors. The company conducts clinical evaluations on the tolerability and effectiveness of products designed for contact with skin, hair, nails, and external mucous membranes, and develops customized protocols for its clients. DERMING SRL primarily serves the cosmetics, cosmeceuticals, dietary supplements, and skin care product industries with its scientific testing services. It is based in Italy.

River Diagnostics

River Diagnostics specializes in non-invasive skin analysis technology within the medical diagnostics sector. The company offers products and services based on Raman Spectroscopy for real-time, in vivo tissue analysis and skin composition measurement. These solutions cater to research and development in dermatology and related fields. It was founded in 2002 and is based in Netherlands.


Kjaya is a company that received a SBIR Phase I grant for a project entitled: Semi-Autonomous Adaptive Neural and Genetic Segmentation of Medical Images. Their Phase I project will implement a physician-assisted, real-time adaptive system for the segmentation of anatomical structures in 3D medical image data. Medical image segmentation seeks to change the representation of an anatomical structure, making it more easily analyzed. Because of the extreme variability of these structures in biological systems, current idiosyncratic manual methods currently in use are tedious, time consuming, and error prone. Image segmentation cannot in general be programmatically solved. The proposed system is a Neural Network (NN) based adaptation of the individual data using parallel Graphics Processing Units (GPUs) and coupled with a Genetic Algorithm (GA) based adaptation across GPU cores. The system will build a diagnostically useful segmentation of the anatomical feature within seconds from an area of interest outlined by a physician using a Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) scan. Fast growth in medical imaging overwhelms available diagnosticians. An intuitive and inexpensive system to quickly and accurately deliver diagnostic relevant segmentation of medical images offers tremendous commercial value. Currently, each scan requires approximately 50 minutes of manual preparation. The diagnosis and treatment of an estimated 20 percent of diseases benefit from medical imaging. Newer scanning technologies have increased in resolution, but such techniques have not made segmenting easier or faster. The proposed method will enable more diagnostics to be done with the quality controlled directly by physicians.


CryoPen is a company focused on the advancement of cryosurgery within the medical sector, providing a cryosurgical system designed for a variety of dermatological procedures. Their main product, the CryoPen Cryosurgical System, utilizes linear compression cooling technology to perform cryosurgery without the use of hazardous cryogenic gases or liquids, offering a safer and more precise alternative to traditional methods. The system is primarily used by healthcare professionals across multiple specialties, including general practice, obstetrics and gynecology, and dermatology, to treat skin lesions and pre-cancerous cervical lesions with minimal scarring and without the need for anesthetic. It was founded in 2005 and is based in Corpus Christi, Texas.

OrthAlign Logo

OrthAlign is a company that specializes in the development of advanced technology for joint surgery, operating within the healthcare and technology sectors. The company's primary offerings include user-friendly, cost-effective technology that aids orthopedic surgeons in achieving precise alignment during hip and knee replacement surgeries. OrthAlign's solutions are primarily utilized within the healthcare industry. It was founded in 2008 and is based in Aliso Viejo, California.


CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.